Galderma Group AG
OTC:GDERF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Galderma Group AG
OTC:GDERF
|
CH |
|
I
|
Icade SA
SWB:3IC
|
FR |
|
Plazza AG
SIX:PLAN
|
CH |
|
Fielmann AG
OTC:FLMNF
|
DE |
|
Ircon International Ltd
NSE:IRCON
|
IN |
|
Piedmont Office Realty Trust Inc
NYSE:PDM
|
US |
|
EQT Corp
NYSE:EQT
|
US |
Wall St Price Targets
GDERF Price Targets Summary
Galderma Group AG
According to Wall Street analysts, the average 1-year price target for GDERF is 254.77 USD with a low forecast of 204.25 USD and a high forecast of 366.23 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GDERF's stock price target?
Price Target
254.77
USD
According to Wall Street analysts, the average 1-year price target for GDERF is 254.77 USD with a low forecast of 204.25 USD and a high forecast of 366.23 USD.
What is the Revenue forecast for Galderma Group AG?
Projected CAGR
13%
Over the last 3 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 8 years is 13%.
What is the Operating Income forecast for Galderma Group AG?
Projected CAGR
16%
Over the last 3 years, the compound annual growth rate for Operating Income has been 30%. The projected CAGR for the next 8 years is 16%.
What is the Net Income forecast for Galderma Group AG?
Projected CAGR
19%
The compound annual growth rate for Net Income over the next 8 years is 19%.
